AU1192501A - Fab i inhibitors - Google Patents

Fab i inhibitors

Info

Publication number
AU1192501A
AU1192501A AU11925/01A AU1192501A AU1192501A AU 1192501 A AU1192501 A AU 1192501A AU 11925/01 A AU11925/01 A AU 11925/01A AU 1192501 A AU1192501 A AU 1192501A AU 1192501 A AU1192501 A AU 1192501A
Authority
AU
Australia
Prior art keywords
4alkyl
het
fab
inhibitors
6alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11925/01A
Other languages
English (en)
Inventor
William H. Miller
Kenneth A. Newlander
Mark A. Seefeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU1192501A publication Critical patent/AU1192501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Semiconductor Lasers (AREA)
AU11925/01A 1999-10-08 2000-10-06 Fab i inhibitors Abandoned AU1192501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15852999P 1999-10-08 1999-10-08
US60158529 1999-10-08
PCT/US2000/027591 WO2001026654A1 (en) 1999-10-08 2000-10-06 Fab i inhibitors

Publications (1)

Publication Number Publication Date
AU1192501A true AU1192501A (en) 2001-04-23

Family

ID=22568552

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11925/01A Abandoned AU1192501A (en) 1999-10-08 2000-10-06 Fab i inhibitors

Country Status (8)

Country Link
EP (1) EP1225895B1 (enExample)
JP (1) JP4961084B2 (enExample)
AT (1) ATE294578T1 (enExample)
AU (1) AU1192501A (enExample)
CO (1) CO5251401A1 (enExample)
DE (1) DE60019954T2 (enExample)
HK (1) HK1049610A1 (enExample)
WO (1) WO2001026654A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
JP4831907B2 (ja) * 1999-10-08 2011-12-07 アフィニアム・ファーマシューティカルズ・インコーポレイテッド ＦａｂＩ阻害剤
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
PE20010635A1 (es) 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
US20030055037A1 (en) * 2000-10-06 2003-03-20 Delombaert Stephane Benzimidazole and indole derivatives as CRF receptor modulators
DK1560584T3 (da) 2001-04-06 2009-05-18 Affinium Pharm Inc Fab I inhibitorer
AU2003298937A1 (en) * 2002-12-06 2004-06-30 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
DK1879877T3 (da) 2005-05-03 2013-04-15 Ranbaxy Lab Ltd Antimikrobielle midler
CN101203504B (zh) * 2005-05-03 2012-11-14 兰贝克赛实验室有限公司 抗微生物剂
JP2009533315A (ja) * 2006-04-10 2009-09-17 ランバクシー ラボラトリーズ リミテッド 抗菌剤
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
CA2842531C (en) 2011-08-10 2019-07-16 Janssen R&D Ireland Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones
EP2742044B1 (en) 2011-08-10 2019-12-04 Janssen Sciences Ireland Unlimited Company Antibacterial homopiperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
EA201590331A1 (ru) 2012-08-10 2016-05-31 Янссен Сайенсиз Айрлэнд Юси Новые антибактериальные соединения
CA2879623C (en) 2012-08-10 2021-11-02 Janssen Sciences Ireland Uc Fused bicyclic azole heterocycle as inhibitors of the enzyme fabi
ES2842443T3 (es) 2016-02-26 2021-07-14 Debiopharm Int Sa Medicamento para el tratamiento de infecciones del pie diabético
IL285204B2 (en) 2019-02-14 2025-02-01 Debiopharm Int Sa Formulation of apavicin, method for its preparation
EP3982975A1 (en) 2019-06-14 2022-04-20 Debiopharm International SA Afabicin for use for treating bacterial infections involving biofilm

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) * 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds

Also Published As

Publication number Publication date
EP1225895B1 (en) 2005-05-04
EP1225895A1 (en) 2002-07-31
ATE294578T1 (de) 2005-05-15
DE60019954T2 (de) 2006-02-23
JP4961084B2 (ja) 2012-06-27
WO2001026654A1 (en) 2001-04-19
CO5251401A1 (es) 2003-02-28
EP1225895A4 (en) 2002-11-13
HK1049610A1 (zh) 2003-05-23
JP2003511415A (ja) 2003-03-25
DE60019954D1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
AU1192501A (en) Fab i inhibitors
DE60029235D1 (en) Fab-i-hemmer
TR200103485T2 (tr) Antibakteriyel bileşikler.
WO2001022953A3 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
MXPA04001889A (es) Inhibidores de la alquin-aril fosfodiesterasa-4.
WO2001066564A3 (en) Gamma-secretase inhibitors
AU2002351752A1 (en) Combined use of a glp-1 compound and another drug for treating dyslipidemia
HK1049656A1 (zh) Fab i抑制剂
CA2402742A1 (en) Method of treating or inhibiting colonic polyps
WO2002057252A3 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
NZ544009A (en) Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
NO996108L (no) 9-oksinerytromycinderivater
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
MXPA03010761A (es) Combinaciones farmaceuticas.
WO2002016312A3 (de) NEUE VERBINDUNGEN, DIE FAKTOR Xa-AKTIVITÄT INHIBIEREN
IL149586A0 (en) Pyrimidine derivatives as selective inhibitors of cox-2
WO2001003685A3 (en) Novel prodrugs for antimicrobial amidines
WO2003053971A8 (en) Pyridoquinoxaline antivirals
WO2003049690A3 (en) Hiv integrase inhibitors
EP1347759A4 (en) ANTIBACTERIAL CONNECTIONS
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
CA2316082A1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
IL162689A0 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
WO2000056315A8 (en) Treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase